A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate, Cefazolin, Ceftriaxone10

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	1 g	IV	not captured	standing	page 350
Fever	adult	15 mg/kg	PO	not captured	standing	page 350
Fever	peds	12.5 mg/kg	IV	not captured	standing	page 350
Fever	peds	15 mg/kg	PO	not captured	standing	page 350
Mild to moderate pain	adult	1 g	IV	not captured	standing	page 350
Mild to moderate pain	adult	15 mg/kg	PO	not captured	standing	page 350
Mild to moderate pain	peds	12.5 mg/kg	IV	not captured	standing	page 350
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	page 350

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	0.1 mg/kg	IV	not captured	standing	page 351
SVT	adult	6 mg	IV	not captured	standing	pages 166, 351
SVT	peds	0.1 mg/kg	IV	not captured	standing	page 351

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 173, 196, 234, 235, 254, 255, 369
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 173, 196, 234, 235, 254, 255, 369
Other	adult	2.5 mg	NEB	not captured	standing	page 369
Other	peds	2.5 mg	NEB	not captured	standing	page 369

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	150 mg	IV	not captured	standing	pages 157, 302
Atrial fibrillation with RVR	adult	150 mg	IV	not captured	standing	pages 157, 302, 353
Other	adult	150 mg	IV	not captured	standing	pages 157, 302, 353
Other	peds	5 mg/kg	IV	not captured	standing	pages 157, 302, 353
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 153, 240, 353
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 153, 240, 353

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 160, 355

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV	not captured	standing	page 356
Bradycardia	adult	0.5 mg	IV	not captured	standing	pages 158, 356
Bradycardia	adult	0.5 mg	IV/IO	not captured	standing	pages 158, 356
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 158, 356
Organophosphate poisoning	adult	2 mg	IV	not captured	standing	page 356
Organophosphate poisoning	adult	2 mg	IV/IO/IM	not captured	standing	pages 174, 356
Other	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 237, 356
Other	peds	0.02 mg/kg	IV/IO	not captured	standing	page 326

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV	not captured	standing	page 357
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 151, 357
Other	adult	1 g	IV	not captured	standing	page 174

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	2 g	IV/IO	not captured	standing	pages 151, 154, 357

Cefazolin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV	not captured	standing	page 217
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	page 225

Ceftriaxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV/IO	not captured	standing	pages 187, 358
Other	adult	50 mg/kg (max 2 g)	IV/IO	not captured	standing	page 247
Other	peds	50 mg/kg	IV/IO	not captured	standing	pages 187, 358
Sepsis	adult	2 g	IV/IO	not captured	standing	pages 187, 358
Sepsis	peds	50 mg/kg	IV/IO	not captured	standing	pages 187, 358

D–F Dexamethasone, Dextrose, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Fentanyl, Furosemide8

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	10 mg	IV/IM	not captured	standing	page 359
Asthma / bronchospasm	peds	0.6 mg/kg	IV/IM	not captured	standing	page 359
Asthma / bronchospasm	peds	0.6 mg/kg	IV/IO/IM	not captured	standing	page 255
Asthma / bronchospasm	peds	10 mg	IV/IM	not captured	standing	page 359
Other	adult	10–100 mg	IV/IO	not captured	standing	pages 197, 359
Other	adult	10–100 mg	IV	not captured	standing	page 359
Other	peds	0.6 mg/kg	IV/IO	not captured	standing	pages 197, 359

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mL	IV/IO	not captured	standing	pages 174, 177, 241, 242, 360
Hypoglycemia	adult	100 mL	IV/IO	not captured	standing	pages 174, 177, 241, 242, 360
Hypoglycemia	peds	2–4 mL/kg	IV/IO	not captured	standing	pages 174, 177, 241, 242, 360
Hypoglycemia	peds	2 mL/kg	IV/IO	not captured	standing	pages 241, 242, 360
Hypoglycemia	peds	2–4 mL/kg	IV/IO	not captured	standing	pages 174, 177, 241, 242, 360
Hypoglycemia	peds	2 mL/kg	IV	not captured	standing	pages 241, 242, 360

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	10 mg	IV	not captured	standing	pages 157, 361
Atrial fibrillation with RVR	adult	10 mg	IV	not captured	standing	pages 157, 361

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	25 mg	IV/IM	not captured	standing	pages 173, 362
Anaphylaxis	peds	1 mg/kg	IV/IM	not captured	standing	pages 173, 362
Anaphylaxis	peds	1 mg/kg	IV	not captured	standing	page 362
Other	adult	50 mg	IV/IM	not captured	standing	pages 173, 362

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	2–20 mcg/kg	IV/IO	not captured	standing	pages 152, 237, 363
Bradycardia	peds	2–20 mcg/kg	IV/IO	not captured	standing	pages 152, 237, 363
Cardiogenic shock	adult	2–20 mcg/kg	IV/IO	not captured	standing	pages 159, 363
Cardiogenic shock	peds	2–20 mcg/kg	IV/IO	not captured	standing	pages 159, 363
Hypotension / shock	adult	2–20 mcg/kg	IV/IO	not captured	standing	pages 187, 363
Hypotension / shock	peds	2–20 mcg/kg	IV/IO	not captured	standing	pages 187, 363
Other	adult	2–5 mcg/kg	IV/IO	not captured	standing	page 363
Other	adult	5–10 mcg/kg	IV	not captured	standing	page 152
Other	adult	5–15 mcg/kg	IV	not captured	standing	page 159
Other	adult	5–10 mcg/kg	IV/IO	not captured	standing	page 363
Other	adult	5–20 mcg/kg	IV	not captured	standing	page 187

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mL	IM	not captured	standing	pages 173, 234, 235, 364
Anaphylaxis	peds	0.2 mL	IM	not captured	standing	pages 173, 234, 235, 364
Asthma / bronchospasm	adult	0.3 mg	SQ	not captured	standing	page 364
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 237, 364
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 237, 364
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 146, 151, 154, 239, 240, 364
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 146, 151, 154, 239, 240, 364
Hypotension / shock	adult	0.5–1 mL	not captured	not captured	standing	page 364
Other	adult	0.3 mg	IV	not captured	standing	pages 173, 364
Other	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 239, 364

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.5–2 mcg/kg	IV	not captured	standing	page 160
Other	adult	0.5 mcg/kg	IV	not captured	standing	page 221
Other	adult	1 mcg/kg	IV/IO	not captured	standing	pages 326, 333
Other	adult	1 mcg/kg	IV/IM/IN	not captured	standing	page 326
Other	adult	1 mcg/kg	IV	not captured	standing	page 223
Other	adult	1 mcg/kg	IV/IO/IN	not captured	standing	page 217
Other	adult	1 mcg/kg	IV/IM	not captured	standing	page 220
Other	peds	0.5–1 mcg/kg	IV	not captured	standing	page 326
Other	peds	1–2 mcg/kg	IV	not captured	standing	page 326
Other	peds	1–3 mcg/kg	IV/IO	not captured	standing	pages 326, 333
Other	peds	2–3 mcg/kg	IV	not captured	standing	page 326
Mild to moderate pain	adult	0.5–2 mcg/kg	IV/IO	not captured	standing	pages 315, 365
Mild to moderate pain	adult	1 mcg/kg	IM/IN	not captured	standing	pages 315, 365
Mild to moderate pain	peds	0.5–1 mcg/kg	IV/IO	not captured	standing	pages 315, 365
Mild to moderate pain	peds	0.5–1 mcg/kg	IM/IN	not captured	standing	pages 315, 365
Severe pain	adult	0.5–2 mcg/kg	IV/IO	not captured	standing	pages 315, 365
Severe pain	adult	1 mcg/kg	IM/IN	not captured	standing	pages 315, 365
Severe pain	peds	0.5–1 mcg/kg	IV/IO	not captured	standing	pages 315, 365
Severe pain	peds	0.5–1 mcg/kg	IM/IN	not captured	standing	pages 315, 365

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5–1 mg/kg	IV/IO	not captured	standing	page 366
Other	adult	0.5–1 mg/kg	IV/IO	not captured	standing	page 366

G–L Glucagon, Ipratropium, Ketamine, Ketorolac, Labetalol, Levalbuterol, Lidocaine, Lorazepam8

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IM	not captured	standing	page 367
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV	not captured	standing	page 367
Hypoglycemia	adult	1 mg	IV/IM/IN	not captured	standing	pages 242, 367
Hypoglycemia	peds	0.5 mg	IV/IM/IN	not captured	standing	pages 242, 367
Other	peds	0.5 mg	IM	not captured	standing	pages 242, 367

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5 mg	NEB	not captured	standing	page 369
Other	adult	0.5 mg	NEB	not captured	standing	page 369
Other	peds	0.5 mg	NEB	not captured	standing	page 369
Other	peds	0.5 mg	NEB	not captured	standing	page 369

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg/kg	IV/IO	not captured	standing	page 370
Other	adult	0.5 mg/kg	IN	not captured	standing	pages 315, 370
Other	adult	1 mg/kg	IV/IO	not captured	standing	page 151
Other	adult	1 mg/kg	IM	not captured	standing	pages 315, 370
Other	adult	2 mg/kg	IV/IO	not captured	standing	pages 326, 370
Other	adult	2 mg/kg	IV	not captured	standing	page 370
Other	adult	2 mg/kg	IV/IO	not captured	standing	pages 327, 370
Other	adult	2 mg/kg	IV/IO	not captured	standing	pages 332, 333
Other	adult	2–3 mg/kg	IM	not captured	standing	page 370
Other	adult	25 mg	IV	not captured	standing	pages 315, 370
Other	peds	1 mg/kg	IV/IO	not captured	standing	pages 327, 370
Other	peds	1 mg/kg	IV/IO	not captured	standing	pages 332, 333
Other	peds	2 mg/kg	IV/IO	not captured	standing	pages 326, 370
Mild to moderate pain	adult	0.5 mg/kg	IN	not captured	standing	pages 315, 370
Mild to moderate pain	adult	25 mg	IV/IO	not captured	standing	pages 315, 370
Procedural sedation	adult	0.5 mg/kg	IV/IO	not captured	standing	page 238
RSI induction	adult	2 mg/kg	IV/IO	not captured	standing	page 333
RSI induction	adult	4 mg/kg	IM	not captured	standing	page 333

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	page 391
Mild to moderate pain	adult	30 mg	IM	not captured	standing	page 391

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20 mg	IV	not captured	standing	pages 184, 371

Levalbuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	1.25 mg	NEB	not captured	standing	pages 196, 254, 255
Asthma / bronchospasm	peds	0.625 mg	NEB	not captured	standing	page 254
Asthma / bronchospasm	peds	0.625 mg	NEB	not captured	standing	pages 196, 254, 255
Asthma / bronchospasm	peds	1.25 mg	NEB	not captured	standing	page 254

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5–1.5 mg/kg	IV/IO	not captured	standing	pages 170, 373
Other	adult	0.5–1.5 mg/kg	IV	not captured	standing	page 170
Other	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 167, 373
Other	adult	1–1.5 mg/kg	IV	not captured	standing	pages 167, 373
Other	adult	100 mg	IV	not captured	standing	pages 168, 373
Other	adult	20–50 mg	IO	not captured	standing	page 373
Other	peds	20–50 mg	IO	not captured	standing	page 373
VF / pulseless VT	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 153, 240, 373
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 153, 240, 373

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.05 mg/kg	IM	not captured	standing	pages 175, 375
Seizure	adult	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 257, 375
Seizure	peds	0.05–0.1 mg/kg	IV/IO/IM	not captured	standing	pages 257, 375
Status epilepticus	adult	2–4 mg	IV/IO	not captured	standing	page 375
Status epilepticus	adult	2–4 mg	IM	not captured	standing	page 375
Status epilepticus	adult	2–4 mg	IV	not captured	standing	page 375
Status epilepticus	peds	0.05–0.1 mg/kg	IV/IO	not captured	standing	page 375
Status epilepticus	peds	0.05–0.1 mg/kg	IM	not captured	standing	page 375

M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose9

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	2–4 g	IV	not captured	standing	page 376
Eclampsia / pre-eclampsia	adult	2–4 g	IV	not captured	standing	page 376
Other	adult	1 g	IV	not captured	standing	page 376
Other	adult	1 g	IV	not captured	standing	pages 168, 376
Other	adult	2 g	IV/IO	not captured	standing	pages 154, 376
Other	adult	2 g	IV/IO	not captured	standing	pages 154, 376
Other	adult	40 mg/kg	IV/IO	not captured	standing	pages 197, 255, 376
Other	peds	40 mg/kg	IV/IO	not captured	standing	pages 197, 255, 376

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	125 mg	IV/IM	not captured	standing	pages 235, 377
Anaphylaxis	peds	1 mg/kg	IV/IM	not captured	standing	pages 235, 377
Anaphylaxis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 235
Other	adult	125 mg	IV/IM	not captured	standing	page 377
Other	peds	1 mg/kg	IV/IM	not captured	standing	page 377

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	pages 175, 378
Other	adult	1–2 mg	IV/IM/IN	not captured	standing	page 196
Other	adult	1–3 mg	IV/IN	not captured	standing	pages 175, 176, 378
Other	adult	2 mg	IV	not captured	standing	page 168
Other	adult	2–5 mg	IV/IO/IM/IN	not captured	standing	pages 195, 378
Other	adult	2.5 mg	IM	not captured	standing	pages 175, 378
Other	peds	0.05–0.1 mg/kg	IV/IO/IN	not captured	standing	page 327
Procedural sedation	adult	2–5 mg	IV/IN	not captured	standing	page 378
RSI induction	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 326, 327, 333
RSI induction	peds	0.05–0.1 mg/kg	IV/IO	not captured	standing	pages 326, 327, 333
Seizure	adult	10 mg	IM	not captured	standing	pages 199, 378
Seizure	adult	2.5 mg	IV/IO	not captured	standing	pages 199, 378
Seizure	adult	5 mg	IN	not captured	standing	pages 199, 378
Seizure	peds	0.2 mg/kg	IV/IO	not captured	standing	pages 199, 378
Seizure	peds	0.2 mg/kg	IN	not captured	standing	pages 199, 378
Seizure	peds	0.2 mg/kg	IM	not captured	standing	pages 199, 378
Seizure	peds	0.2 mg/kg	IV/IO/IM/IN	not captured	standing	page 378

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	1–5 mg	IV/IO	not captured	standing	page 380
Other	adult	2–10 mg	IV	not captured	standing	page 220
Other	adult	2–4 mg	IV	not captured	standing	page 159
Mild to moderate pain	adult	2–4 mg	IV/IO	not captured	standing	page 380
Mild to moderate pain	peds	0.1–0.2 mg/kg	IV/IO	not captured	standing	page 380
Mild to moderate pain	peds	0.1–0.2 mg/kg	IM/SQ	not captured	standing	page 380
Mild to moderate pain	peds	0.1–0.2 mg/kg	IV/IM/SQ	not captured	standing	page 380

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.5 mg	IV/IO/IM	not captured	standing	pages 194, 253, 381
Opioid overdose	adult	2 mg	IN	not captured	standing	pages 194, 253, 381
Opioid overdose	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 194, 253, 381
Opioid overdose	peds	1 mg	IN	not captured	standing	pages 194, 253, 381
Other	adult	0.4 mg	IV/IM	not captured	standing	page 174
Other	adult	0.5 mg	IN	not captured	standing	page 194
Other	adult	1 mg	IN	not captured	standing	pages 194, 195
Other	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	page 253

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	0.8 mg	SL	not captured	standing	pages 164, 382
Other	adult	0.4 mg	SL	not captured	standing	pages 160, 382
Other	adult	0.4 mg	SL	not captured	standing	page 184

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Sepsis	adult	1–10 mcg	IV	not captured	standing	pages 185, 187, 383

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IO/ODT	not captured	standing	pages 192, 249, 384
Nausea / vomiting	adult	4 mg	IM	not captured	standing	pages 192, 384
Nausea / vomiting	peds	0.1 mg/kg	IV/IO/ODT	not captured	standing	pages 192, 249, 384
Nausea / vomiting	peds	0.1 mg/kg	IV/IO	not captured	standing	page 249
Other	adult	4 mg	IV/IM/ODT	not captured	standing	page 192

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	BUC	not captured	standing	pages 241, 368
Hypoglycemia	adult	15 g	BUC	not captured	standing	pages 174, 241, 247, 311, 360, 368
Hypoglycemia	peds	15 g	BUC	not captured	standing	pages 174, 241, 247, 311, 360, 368
Hypoglycemia	peds	7.5 g	BUC	not captured	standing	pages 241, 368

P–R Promethazine, Racemic Epinephrine, Rocuronium3

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	12.5 mg	IV	not captured	standing	pages 192, 385
Nausea / vomiting	adult	25 mg	IM	not captured	standing	pages 192, 385
Other	adult	12.5 mg	IV	not captured	standing	page 192
Other	adult	12.5 mg	IV	not captured	standing	page 217
Other	adult	25 mg	IM	not captured	standing	page 192

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Croup	peds	0.5 mL	NEB	not captured	standing	pages 255, 386
Other	adult	0.5 mL	NEB	not captured	standing	pages 255, 386
Other	peds	0.5 mL	NEB	not captured	standing	pages 255, 386

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mg/kg	not captured	not captured	standing	page 326
Other	peds	1 mg/kg	not captured	not captured	standing	page 326
RSI induction	adult	1 mg/kg	not captured	not captured	standing	page 387
RSI induction	adult	1 mg/kg	IV	not captured	standing	pages 326, 387
RSI induction	peds	1 mg/kg	IV	not captured	standing	pages 326, 387

S–Z Sodium Bicarbonate, Succinylcholine, Terbutaline, Thiamine, Tranexamic Acid5

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1 mEq/kg	IV/IO	not captured	standing	pages 151, 154, 239, 388
Cardiac arrest	peds	1 mEq/kg	IV/IO	not captured	standing	pages 151, 154, 239, 388
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 151, 174, 388
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 223, 388
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 151, 174, 388
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 223, 388

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 mg/kg	IV/IO	not captured	standing	page 389
Other	adult	3–4 mg/kg	IM	not captured	standing	page 389
Other	peds	1 mg/kg	IV/IO	not captured	standing	page 326
Other	peds	1 mg/kg	IV/IO	not captured	standing	page 389
Other	peds	2 mg/kg	IV/IO	not captured	standing	page 326
Other	peds	2 mg/kg	IV/IO	not captured	standing	page 389
RSI paralysis	adult	2 mg/kg	IV	not captured	standing	pages 326, 389
RSI paralysis	peds	1 mg/kg	IV	not captured	standing	pages 326, 389

Terbutaline

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.25 mg	SQ	not captured	standing	pages 197, 392

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	IV/IM	not captured	standing	pages 156, 174, 390
Other	adult	100 mg	IV/IO	not captured	standing	page 156

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mL	IN	not captured	standing	pages 193, 393
Other	adult	2 g	IV/IO	not captured	standing	page 169
Trauma / hemorrhage	adult	1 g	IV	not captured	standing	pages 218, 393
Trauma / hemorrhage	adult	2 g	IV/IO	not captured	standing	pages 169, 217, 223, 393

Benbrook Fire Department

Drugs and doses43